i agree with this. but we remain a company with no approved drug and no revenue. remember - no one knows (or really cares) about us - as haven't gotten an approval on anything.

once we get either COVID or HIV across the goal line for an actual approval to sell the drug, the doors will open. Until then, we're in no-man's land.

i reman hopeful that Brazil is starting. great PR today, but not the one i'm looking for - i already knew we had strong initial TNBC results - yeah, this is more info, but nothing new.

If i were a skeptic, i'd say the company put this PR out given that they're unable to put the one out that really matters right now - starting the Brazil COVID trial. for me, it's the elephant in the room, because everything else is next year at least.